Ribosomal multilocus sequence typing: universal characterization of bacteria from domain to strain

Keith A. Jolley, Carly M. Bliss, Julia S. Bennett, +8

Microbiology

GeneticsBacteriologyMolecular BiologyGenomicsHigh Throughput Sequencing +15

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Katie Ewer, Tommy Rampling, Navin Venkatraman, +52

New England Journal of Medicine

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Raffael Nachbagauer, Jodi Feser, Abdollah Naficy, +30

Nature Medicine

VaccinationCross-protectionVaccine DevelopmentVaccine TargetImmunology +8

Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species

Stefano Colloca, Eleanor Barnes, Antonella Folgori, +22

Science Translational Medicine

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

Alec W. Freyn, Jamile Ramos da Silva, Victoria Rosado, +12

Molecular Therapy

ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans

Susanne H. Sheehy, C.J. Duncan, Sean C. Elias, +29

Molecular Therapy

Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against <i>Plasmodium falciparum</i> infection in Kenyan adults

Caroline Ogwang, Domtila Kimani, Nick J. Edwards, +17

Science Translational Medicine

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals

Susanne H. Hodgson, Katie Ewer, Carly M. Bliss, +25

The Journal of Infectious Diseases

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01_BWith Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP

Tommy Rampling, Katie Ewer, Georgina Bowyer, +27

The Journal of Infectious Diseases

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children

Alfred B. Tiono, Issa Nébié, Nicholas Anagnostou, +21

PLoS ONE